Drug intelligence / Profile preview

Measles and Mumps Combined Vaccine, Live (SIBP)

Development stage
Unknown
Lead developer
Shanghai Institute of Biological Products
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

Measles and Mumps Combined Vaccine, Live (SIBP) is a live attenuated combination vaccine developed to provide active immunization against measles and mumps. The vaccine contains weakened forms of the measles virus and the mumps virus that stimulate the immune system to produce protective antibodies without causing disease. Upon administration, it induces an immune response resulting in long-lasting immunity against both viruses. This vaccine is primarily indicated for the prevention of measles and mumps infections in children. It is developed by Shanghai Institute of Biological Products Co., Ltd., which is also known for producing a combined measles, mumps, and rubella (MMR) vaccine[4]. The SIBP formulation does not include rubella.

Other names
Measles and Mumps Combined Vaccine, Live (SIBP)Live Attenuated Measles and Mumps Combined Vaccine

Beyond the preview

Go deeper on Measles and Mumps Combined Vaccine, Live (SIBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Measles and Mumps Combined Vaccine, Live (SIBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call